DNase I could be the most important nuclease for the removal of DNA from nuclear antigens at sites of high cell turnover, and thus may also prevent systemic lupus erythematosus (SLE). Sixteen SNPs were identified by direct DNA sequencing, among which six were selected for genotyping in a larger investigation on the basis of linkage disequilibria among SNPs, their frequency, location and haplotype tagging status. Genetic associations of polymorphisms in DNase I with the risk of SLE and the production of common autoantibodies were examined in a Korean population (350 SLE patients and 330 controls). Although no significant associations with the risk of SLE were found, logistic regression analyses revealed that one non-synonymous SNPs in exon 8, 12373A>G(Gln244Arg), was significantly associated with an increased risk of the production of anti-RNP and anti-dsDNA antibodies among SLE patients. The frequency of the homozygous minor allele (Arg/Arg) was much higher in patients who had the anti-RNP antibody (31.3%) than in patients who did not have this antibody (14.4%) (P 5 0.0006, OR 5 2.86). In addition, the A/T mutation in exon 2 of DNase reported in two Japanese SLE patients was not present in SLE patients (n 5 350) or controls (n 5 330) in our Korean population, which combined with the results of previous reports strongly suggests that the mutation is not present in three major ethnic groups: Caucasian, African and Asian.
INTRODUCTION
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by immune dysregulation that leads to a high level of autoantibody (auto-Ab) production, immunecomplex deposition and tissue injury. Patients with SLE manifest with a diverse array of clinical symptoms that can involve multiple organ systems. The etiology of SLE is complex, involving environmental and genetic factors both independently and, most probably, synergistically. Genetic factors are likely to play a significant role in the susceptibility to SLE, in determining the disease expression and in the auto-Ab profile exhibited by individuals with SLE (1) .
Lower serum DNase activity observed in SLE patients could be causing abnormalities in the function of enzymes responsible for clearance of postapoptotic products and, consequently, could be an important pathogenesis of SLE (2) . DNase I and DNase II are the primary enzymes involved in the metabolism and clearance of DNA.
One nonsense mutation in exon 2 of DNase I, with decreased DNase I activity and an extremely high immunoglobulin G titer against nucleosomal antigens, has been reported in two Japanese SLE patients (3) . However, analyses of 1516 chromosomes of Caucasian (4) and 260 chromosomes of African, including SLE patients (5) , showed the absence of this mutation. To confirm the absence or presence of this mutation in the Korean population, whose genetic background is very similar to that of the Japanese population (6), we explored the A/T mutation of DNase I in SLE patients and controls (n ¼ 680).
Human Molecular Genetics, Vol. 13, No. 20 # Oxford University Press 2004; all rights reserved Furthermore, to investigate the possible involvement of genetic polymorphisms of DNase I in SLE, additional polymorphisms were scrutinized by direct DNA sequencing of the whole gene, including 1500 bp of the 5 0 flanking region. The genetic associations of additional polymorphisms (identified in this study) with the risk of SLE and production of auto-Abs were examined in Korean patients with SLE.
RESULTS
Genotyping and direct DNA sequencing revealed that neither Korean SLE patients (n ¼ 350) nor Korean controls (n ¼ 330) carried any A/T mutation in exon 2 of DNase I reported in two Japanese SLE patients (3).
We then investigated the possible existence of polymorphisms in DNase I by direct DNA sequencing of the whole gene, including 1500 bp of the 5 0 flanking region, in 12 SLE patients and 12 healthy subjects. Fifteen SNPs, including three known SNPs, were identified: three in the 5 0 regulatory region, five in introns and seven in exons (four non-synonymous SNPs) (Fig. 1) . The frequencies of the minor alleles of DNase I SNPs are shown in Figure 1A . Pairwise comparisons among SNPs revealed one set of absolute linkage disequilibria (LDs) (jD 0 j ¼ 1 and r 2 ¼ 1):22125A. C:21900T.C:21494C.G:2778G.A:2637G.A:216C .T. Several complete LDs (jD 0 j ¼ 1 and r 2 ¼ 1) were also found (Fig. 1C) . LDs among SNPs and haplotypes inferred by PHASE software (7) are also shown in Figure 1B and C. Only two common (frequency.0.05) haplotypes (ht1 and ht2) were used for haplotype association analysis.
Six of these SNPs [22125A.C, þ273C.T, þ1649C.G (Pro154Ala), þ2035C.G, þ2120C.T and þ2373A.G (Gln244Arg) ] were selected for genotyping in a larger investigation (350 SLE patients and 330 controls) on the basis of LDs among SNPs, their frequency, location and haplotype tagging status. For comparison of allele frequencies with those in other major ethnic groups, we also genotyped 50 Caucasian and 50 African-American DNA samples obtained from the Human Genetic Cell Repository (http://locus.umdnj.edu/ nigms/) (Fig. 1B) . The genotype distributions of DNase I SNPs in SLE patients and normal subjects were analyzed with multiple logistic regression models. No significant genetic associations were found between DNase I polymorphisms and the risk of SLE ( Table 1 ). The genetic associations with the production of three common auto-Abs [anti-Ro, -RNP (ribonucleoprotein) and -dsDNA Abs] were also tested. One non-synonymous SNP [þ2373A.G(Gln244Arg) ], one nearby intronic SNP (þ2035C.G ) and two common haplotypes (ht1 and ht2) were significantly associated with an increased risk of anti-RNP (P ¼ 0.003, 0.003, 0.0007 and 0.001, respectively) and anti-dsDNA Abs production (P ¼ 0.02, 0.04, 0.03 and 0.11, respectively) among SLE patients (Table 2) . It is more likely that the significant associations of ht1[A-C-C-C-C-C-A ] and ht2[A-C-C-C-G-C-G ] come from þ2373A.G(Gln244Arg) and þ2035C.G, considering that ht1 and ht2 are tagged by the A allele (Gln) of þ2373A.G(Gln244Arg) (.94%) and the G allele of þ2035C.G (.96%), respectively (Fig. 1B) . Similarly, the positive signals of the nearby intronic SNP, þ2035C.G, might be tracking the effect of nearby non-synonymous SNP, þ2373A.G(Gln244Arg), in exon 8 due to the strong LD (jD 0 j ¼ 1) (Fig. 1C) . The genetic effect of þ2373A. G(Gln244Arg) was therefore analyzed further.
The higher risk and stronger association of the homozygotes for minor allele (Arg/Arg) of þ2373A.G(Gln244Arg) (OR ¼ 1.77, P ¼ 0.002) than those of heterozygotes (Gln/ Arg) (OR ¼ 1.21, P ¼ 0.54) in reference analyses indicate that it is more likely that this allele has a recessive effect on the production of the anti-RNP Abs. A similar association with anti-dsDNA Ab production was also detected (data not shown), which was a weaker signal than the anti-RNP Ab. The frequency of the homozygous minor allele (Arg/Arg) was much higher in patients who had the anti-RNP Ab (31.3%) than in patients who did not have the anti-RNP Ab (14.4%) (P ¼ 0.0006, OR ¼ 2.86) ( Table 3 ).
The effects of þ2373A.G(Gln244Arg) on the production of both anti-dsDNA Ab and anti-RNP Ab were also analyzed. The allele frequencies among patients carrying both auto-Abs (n ¼ 58), only one auto-Ab (n ¼ 203) and no auto-Abs (n ¼ 64) are shown in Figure 2 , which clearly indicates that the allele frequencies increased with susceptibility to auto-Ab production (P ¼ 0.00004).
DISCUSSION
Like other autoimmune diseases, SLE shows a strong genetic predisposition. This disease shows a high concordance in identical twins and occurs with increased frequency among first-degree relatives of patients. An analysis of multiplex families suggested that the genetic component of disease susceptibility involves a set of unlinked genes that operate in concert to induce either SLE or other autoimmune diseases (8) .
The present results show that the SNPs in DNase I are not associated with the risk of SLE, but one non-synonymous SNP in exon 8, þ2373A.G(Gln244Arg), is significantly associated with an increased production of anti-RNP and anti-dsDNA Abs among SLE patients. In addition, neither SLE patients (n ¼ 350) nor controls (n ¼ 330) carried any A/T mutation in exon 2 of DNase I, which has been reported in two Japanese SLE patients (3). The absence of this mutation in our Korean population, combined with the results of previous reports (4, 5) , strongly suggests that the mutation reported previously in Japanese SLE patients is not present in the three major ethnic groups.
A large array of auto-Abs are found in the serum of SLE patients, including Abs to single-and double-stranded DNA, histone, DNA-histone complex, some nuclear RNA proteins (Sm, nRNP) and cytoplasmic antigens (Ro, La). However, the existence of these auto-Abs is not sufficient to evoke an autoimmune disease. Anti-dsDNA Abs are intimately associated with SLE, and their presence has both diagnostic and prognostic significance. Chromatin and nucleosomes have been proposed as the antigens initiating the formation of Abs that are potentially pathogenic to DNA. In addition to this central role of chromatin and nucleosomes, nucleosome-activated T lymphocytes from patients with SLE can help B lymphocytes produce IgG Abs to DNA. The ability to make Abs to chromatin, nucleosomes and DNA may depend in part on genetic susceptibility. Auto-Abs directed against the snRNP (small nuclear RNP) autoantigens, referred to as RNPs, were originally detected in the sera of SLE patients and are present in about onethird of patients with SLE (9) . The snRNPs are a group of nuclear particles comprising several polypeptides associated with a small nuclear RNA molecule. The most abundant snRNPs are involved in pre-mRNA splicing. RNP auto-Abs are able to precipitate one particular type, referred to as U1 snRNA. Anti-RNP Abs react with the U1-snRNP-specific polypeptides.
Many recent studies have implicated an important role for cell-death processes in mediating the bypass of tolerance to autoantigens such as chromatin, nucleosome, DNA and snRNPs, although the underlying mechanisms are poorly understood. A previous study revealed that lymphocytes from SLE patients showed a higher rate of apoptosis compared with lymphocytes from rheumatoid arthritis patients or normal donors (10) . It has also been shown that autoantigens targeted in SLE become concentrated in two discrete populations of surface structures on apoptotic cells, namely, apoptotic bodies and apoptotic surface blebs. This increased rate of apoptosis could lead to overloading on the phagocytic system with apoptotic cell material, resulting in an increased amount of intracellular components in the serum of these patients. This intracellular material would be recognized as non-self-antigens by immunocompetent cells, leading to the formation of auto-Abs against intracellular particles. Therefore, several events (e.g., dysregulated apoptosis and phagocytosis) might contribute to the development of SLE and/or production of auto-Abs to intracellular components. DNase I, which is present in serum, urine and secreta, encodes a nuclease that has the potential to remove DNA and to preferentially attack double-stranded DNA and produces 5 0 phosphoryl oligonucleotides at sites of high cell turnover. Mice deficient of this enzyme show SLE-like features (11) . A hallmark of apoptosis is the cleavage of chromatin by caspase-activated DNase (12) . This fragmentation occurs at the internucleosomal level and leads to the formation of DNA ladders classically associated with apoptosis (13) . The dysregulation of DNA fragmentation due to defective DNase I might be directly linked to the production of Abs to dsDNA or nucleosomes in concert with increased apoptosis and impaired phagocytosis in patients with SLE.
The present study suggests that the substitution of Gln (an uncharged R group) to Arg (a positively charged R group) in the þ2373A.G(Gln244Arg) SNP of DNase I could cause conformational changes in the expressed protein, and subsequently could influence enzyme activity and result in the high production of anti-RNP and anti-dsDNA Abs in the sera of SLE patients.
The correction of P values obtained from multiple tests of SNPs in a single gene (or a single LD block) with related phenotypes would be complicate issue when considering the following factors: (1) generally, most markers in single genes are in strong LDs and are not independent (and not completely dependent either), (2) haplotypes constructed by combinations of SNPs are not independent of SNPs and (3) alternative analyses (e.g., the referent, codominant, dominant and recessive models in the present study) might be performed with closely related phenotypes (auto-Abs in this study). In the case of DNase I, DNase I þ2035G.C and þ2373A. G(Gln244Arg) for anti-RNP auto-Abs (Table 2) would retain significance after Bonferroni correction, whereas a weak association with anti-dsDNA auto-Abs would disappear. Therefore, further biological and/or functional evidence is needed to confirm the association of DNase I polymorphisms with auto-Abs shown in this study.
In conclusion, (1) 15 SNPs were identified, including three known and four non-synonymous ones, (2) one nonsynonymous SNP in exon 8, þ2373A.G(Gln244Arg), was significantly associated with an increased risk of the production of anti-RNP and anti-dsDNA Abs among Korean SLE patients and (3) the A/T nonsense mutation in exon 2 of DNase I reported by Yasutomo et al. (3) was not found in either SLE patients or controls in a Korean population.
MATERIALS AND METHODS

Patients
A total of 350 Korean patients who fulfilled the 1997 ACR (American College of Rheumatology) criteria for SLE (14) were consecutively enrolled from the Hospital for Rheumatic Diseases, Hanyang University, Seoul, South Korea. Antinuclear Abs were tested by indirect immunofluorescence using IT-1 cells: anti-dsDNA Abs by Crithidia luciliae assay; and anti-Sm, -SSA (Ro), -SSB (La) and -RNP Abs by double immunodiffusion. As a control group, we included 330 healthy ethnically matched subjects in order to examine the genetic association with susceptibility to SLE and related phenotypes. Written informed consent was obtained from each subject. The clinical parameters are summarized in Table 4 .
Sequencing analysis of the human DNase I gene
We have sequenced exons and their boundaries of the DNase I gene, including the promoter region (1500 bp), to discover genetic variants in 12 SLE patients and 12 healthy subjects using a DNA analyzer (ABI PRISM 3700, Applied Biosystems, Foster City, CA, USA). Information regarding primers is available on our website (http://www.snp-genetics.com/ user/news_content.asp?board_idx ¼ 175). Sequence variants were verified using chromatograms.
Genotyping with fluorescence polarization detection
For genotyping of six polymorphic sites [22125A.C, þ273C.T, þ1649C.G(Pro154Ala), þ2035C.G, þ2120C.T and þ2373A.G(Gln244Arg) ], amplifying primers and probes were designed for TaqMan (15) . Primer Express (Applied Biosystems) was used to design both the PCR primers and the MGB TaqMan probes. One allelic probe was labeled with the FAM dye and the other with the Table 2 . Frequencies of minor alleles of DNase I polymorphisms and logistic analysis of allelic distributions with the production of three common auto-Abs (anti-Ro, -RNP and -dsDNA Abs) detected among SLE patients controlling for age, disease duration and sex as covariates among SLE patients 
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fluorescent VIC dye. PCRs were run in a TaqMan Universal Master mix without UNG (Applied Biosystems) with PCR primer concentrations of 900 nM and TaqMan MGBprobe concentrations of 200 nM. Reactions were performed in a 384-well format in a total reaction volume of 5 ml using 20 ng of genomic DNA. The plates were then placed in a thermal cycler (PE 9700, Applied Biosystems) and heated at 508C for 2 min and 958C for 10 min, followed by 40 cycles of 958C for 15 s and 608C for 1 min, with a final soak at 258C. The TaqMan assay plates were transferred to a Prism 7900HT instrument (Applied Biosystems) where the fluorescence intensity in each well of the plate was read. Fluorescence data files from each plate were analyzed by automated allele-calling software (SDS 2.1). Information regarding the probes is available on our website (http:// www.snp-genetics.com/user/news_content.asp?board_idx ¼ 175).
Statistics
We examined Lewontin's D 0 (jD 0 j) and the LD coefficient r 2 between all pairs of biallelic loci (16, 17) . Haplotype associations were estimated using Haplo.Score (http://www.biostat. wustl.edu/genetics/geneticssoft/), which imputes score statistics to test associations between haplotypes and a wide variety of traits, including binary, ordinal, quantitative and Poisson (18) . This software provides several haplotype-specific tests for association, as well as adjustment for non-genetic covariates and computation of simulation P-values, using the assumption that all subjects are unrelated and that haplotypes are ambiguous owing to unknown linkage phases of the genetic markers. Genotype distributions of DNase I SNPs among SLE patients and normal subjects were analyzed with logistic regression models while controlling for age, sex and disease duration as covariates. 
